1. Home
  2. Analysis
  3. Multiple-sclerosis
  4. Intra-abdominal-haemorrhage

Multiple sclerosis and Intra-abdominal haemorrhage

Summary:

Intra-abdominal haemorrhage is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Intra-abdominal haemorrhage with Multiple sclerosis. It is created by eHealthMe based on reports of 59 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,084 drugs and 1,366 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Intra-abdominal haemorrhage?

Intra-abdominal haemorrhage (intra-abdominal bleeding) is found to be associated with 355 drugs and 519 conditions by eHealthMe. Check the latest studies of Intra-abdominal haemorrhage.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

59 people who have Multiple Sclerosis and Intra-Abdominal Haemorrhage are studied.

Would you have Intra-abdominal haemorrhage when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Intra-Abdominal Haemorrhage *:

  • female: 87.93 %
  • male: 12.07 %

Age of people who have Multiple Sclerosis and experienced Intra-Abdominal Haemorrhage *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 8.7 %
  • 30-39: 8.7 %
  • 40-49: 21.74 %
  • 50-59: 34.78 %
  • 60+: 26.09 %

Common co-existing conditions for these people *:

  1. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 1.69%
  2. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 1.69%
  3. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 1.69%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 1.69%
  5. Aplastic Anemia: 1 person, 1.69%

Common drugs taken by these people *:

  1. Aubagio: 17 people, 28.81%
  2. Avonex: 17 people, 28.81%
  3. Escitalopram: 13 people, 22.03%
  4. Tysabri: 9 people, 15.25%
  5. Rebif: 5 people, 8.47%
  6. Tecfidera: 4 people, 6.78%
  7. Gilenya: 3 people, 5.08%
  8. Tizanidine Hydrochloride: 2 people, 3.39%
  9. Sertraline Hydrochloride: 2 people, 3.39%
  10. Symbicort: 2 people, 3.39%

Common symptoms for these people *:

  1. Weight Decreased: 20 people, 33.90%
  2. Fever: 19 people, 32.20%
  3. Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 18 people, 30.51%
  4. Nausea And Vomiting: 18 people, 30.51%
  5. Nausea (feeling of having an urge to vomit): 18 people, 30.51%
  6. Malaise (a feeling of general discomfort or uneasiness): 17 people, 28.81%
  7. Abdominal Pain: 17 people, 28.81%
  8. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 15 people, 25.42%
  9. Lipase Increased: 15 people, 25.42%
  10. Tumor Marker Increased: 15 people, 25.42%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Intra-abdominal haemorrhage?

- Check whether Intra-abdominal haemorrhage is associated with a drug or a condition

Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Intra-abdominal haemorrhage:

All the conditions that are associated with Intra-abdominal haemorrhage:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Intra-abdominal haemorrhage and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.